Nanoveu’s $2M Placement Fuels High-Stakes Commercialisation Push

Strategic Capital Injection

Nanoveu Limited (ASX, NVU) has successfully raised A$2 million through a placement of over 36 million shares priced at 5.5 cents each. This capital raise attracted strong interest from both new and existing sophisticated investors, underscoring confidence in Nanoveu's recent technological milestones and growth trajectory.

The funds will be primarily deployed to finalise the tape-out of Nanoveu’s advanced 16nm ECS-DoT system-on-chip (SoC), a critical step towards commercialisation. This chip development, conducted in partnership with the Centre of Nanoelectronics and Devices, promises ultra-low-power AI processing capabilities tailored for smart devices and edge computing applications.

Advancing Drone Trials and AIoT Platform Rollout

Building on earlier successes that demonstrated a 33% increase in simulated drone flight time, Nanoveu is now conducting Phase 2 drone trials aiming for a 40-70% improvement in endurance across diverse flight conditions. Results from these trials are expected within the current quarter and could validate the practical benefits of Nanoveu’s semiconductor innovations in real-world applications.

Alongside chip development, the company is accelerating the rollout of its EMASS modular AIoT platform. This platform integrates Nanoveu’s cutting-edge SoCs with smart coatings and glasses-free 3D solutions, such as the EyeFly3D display technology and Nanoshield antimicrobial films. These complementary technologies position Nanoveu at the intersection of several high-growth markets, including AI, IoT, renewable energy, and digital 3D content.

Global Expansion and Market Positioning

Nanoveu’s strengthened balance sheet supports its ambitions for global expansion, including ongoing field trials of Nanoshield Solar in Morocco and the UAE. The company is also progressing an application for a dual listing on the U.S. OTCQB market, a move designed to broaden its investor base and enhance liquidity as it scales internationally.

Executive Chairman Dr David Pevcic highlighted the significance of this funding round, noting that with 22nm silicon already in hand and the 16nm architecture ready for fabrication, Nanoveu is at a pivotal juncture. The company is poised to transition from development to scalable commercial deployment, leveraging its diverse technology portfolio.

Overall, this capital raise not only fuels Nanoveu’s immediate development milestones but also signals growing market confidence in its innovative semiconductor and AIoT solutions.